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Abstract--Human somatic cell variants resistant to the arginine analog, canavanine, express 
200-fold increased levels of argininosuccinate synthetase (AS) mRNA as compared to 
parental cells. In this study we examined whether AS cDNA sequences contain cis-acting 
regulatory elements that are involved in the induction of AS mRNA in canavanine-resistant 
cells. Minigene constructs containing AS cDNA sequences under the transcriptional control of 
a viral promoter were stably transfected into the human squamous cell carcinoma line, RPMI 
2650. Upon conversion of cells to canavanine-resistance, expression of the endogenous AS gene 
increased by two orders of magnitude as expected. Surprisingly, however, expression of AS 
cDNA minigenes decreased I0- to 15-fold in canavanine-resistant cell variants. The observed 
down-modulation of AS cDNA minigene expression was dependent upon a concomitant 
induction of the endogenous AS gene and not simply expression of the canavanine-resistant 
phenotype. This paradoxical regulation was specific for AS gene sequences since a minigene 
containing the neomycin-resistance gene in place of AS cDNA sequences failed to regulate. 
Furthermore, minigenes lacking a substantial portion of the AS cDNA also failed to exhibit 
the down-modulation. These findings suggest that expression of the human AS gene is 
regulated by a specific and limiting, positively-acting, trans-acting mechanism in canavanine- 
resistant cells and that exogenous AS cDNA (mRNA) sequences can compete for this 
mechanism. 
INTRODUCTION 
Rare variants of nonhepatic cells that 
express high levels of AS mRNA,  equivalent 
to tllO~;~ ill "'-- ' - "  ..... can be :-^'- '^'~ ~" . . . .  ' ~  
tion in the presence of the arginine analog, 
canavanine (1). The human squamous cell 
carcinoma line, R P M I  2650, gives rise to 
variants at a frequency of 10 6-10-7 when 
using micromolar concentrations of canavan- 
ine. Interestingly, these canavanine-resistant 
cell variants stably express 200-fold increased 
levels of AS m R N A  as compared to parental 
R P M I  2650 cells without amplification of AS 
genomic sequences (1). Previous studies using 
AS promoter-gone fusions showed that the 
human A~S promoter was net more transcrip- 
tionally active in canavanine-resistant cell 
variants when added exogenously (2, 3). 
These results raised the possibility that the 
regulatory elements that are necessary for the 
induction of AS m R N A  in canavanine-resis- 
tant cells might be intragenic. This possibility 
is the subject of the present report. 
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MATERIALS AND METHODS 
Construction of RSV-AS Expression 
Plasmids. RSV-AS contains sequences from 
the AS cDNA, pAS419 (4), from the AvaI 
site at base 1 to the PvulI site at base 1510 
(5). These sequences were cloned between the 
HindlII and BgllI sites of RSV/3-globin (6), 
after removal of the/3-globin sequences. RSV- 
AS A HindlII was constructed by digesting 
RSV-AS with HindlII, filling in the recessed 
ends with the Klenow subunit of DNA poly- 
merase, followed by ligation with T4 DNA 
ligase. RSV-AS A HindlII was verified as 
being unable to produce a functional AS gene 
product by transfection of Chinese hamster 
RJK88 cells followed by selection in medium 
lacking arginine but containing citrulline 
(DMEM-a+c)  (2). RJK88 cells lack endog- 
enous AS act ivi ty  and will die in 
D M E M - a + c  unless complemented with an 
exogenous and functional AS gene. RSV-AS 
A HindlI1 failed to yield colonies in this assay 
whereas the parental plasmid, RSV-AS, pro- 
duced hundreds of colonies. RSV-AS A 
HindlII-ter was constructed as follows. The 
plasmid pAS412/pUC-8, which contains the 
1.3-kb PstI cDNA insert of pAS412 (5) 
cloned into the PstI site of pUC-8, was 
digested with BamHI and HindlII. A 250-bp 
Bam HI-HindlII fragment, which contains 
the first 232 bp of the AS cDNA, was isolated, 
and the ends were made blunt with the Kle- 
now subunit of DNA polymerase. This 
blunted fragment was then cloned between 
the HindlII and BgllI sites of RSV/3-globin 
after removal of the ~-globin sequences and 
blunting of the HindlII and BgllI ends with 
the Klenow subunit of DNA polymerase. 
Cell Culture and Plasmid DNA Trans- 
fections. The maintenance of cell lines in 
culture, selection of canavanine-resistant cell 
variants and plasmid DNA transfections were 
performed as previously described (2, 7). In a 
typical experiment, 10-20 canavanine-resis- 
tant colonies were obtained in three to four 
weeks from 1-2 • 1 0  7 cells. The cells were 
then pooled and grown en masse for prepara- 
tion of RNA. Quantification of the endoge- 
nous AS RNA and RSV-AS RNA was per- 
formed within two to four weeks following 
pooling of canavanine-resistant colonies to 
minimize the outgrowth of nonrepresentative 
clones. 
S1 Nuclease Assays. Total cellular 
RNA was isolated using the guanidinium 
isothiocyanate-CsC1 density gradient method 
(8). DNA probes for S1 nuclease assays were 
prepared by 5'-end labeling the DNA using 
[32P]3,-ATP and polynucleotide kinase (8). S1 
nuclease assays were performed using total 
cellular RNA as previously described (2, 7). 
Reaction products were applied to 8% poly- 
acrylamide sequencing gels and protected 
fragments were visualized by autoradiogra- 
phy. 
RESULTS 
To test the possibility that AS exon 
sequences were involved in the 200-fold induc- 
tion of AS mRNA in canavanine-resistant 
cells, we constructed the expression plasmid 
RSV-AS (Fig. 1). RSV-AS contains a nearly 
full-length AS cDNA positioned downstream 
of the Rous sarcoma virus (RSV) promoter. 
This cDNA lacks the first 27 bases of exon 1 
and the last 37 bases of the terminal exon, 
which includes polyadenylation signal se- 
quences. Splicing and polyadenylation func- 
tions are provided by the vector. Cloned 
RPMI 2650 cell lines stably expressing RSV- 
AS were obtained by cotransfection of RSV- 
AS plasmid DNA with the dominant select- 
able marker gene, RSVneo (6). Cell lines were 
screened for expression of RSV-AS mRNA 
by S1 nuclease assays (data not shown), and 
canavanine-resistant variants for each ex- 
pressing cell line were obtained by selection in 
media containing 3 #M canavanine (2). 
Expression of the endogenous AS gene and 
RSV-AS cDNA minigene in parental cells 
and in pooled canavanine-resistant cell lines 
was examined using quantitative S1 nuclease 
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Fig. 1. Diagram of RSV-AS. Solid box, RSV promoter 
sequences; stippled box, AS 5'-untranslated sequences; 
open box, AS coding sequences; hatched box, AS 3'- 
untranslated sequences; thin line, SV40 splicing and 
polyadenylation sequences; thick line, procaryotic vector 
sequences. The arrow indicates the transcription initia- 
tion site. A, AvaI; B, BamHI; H, HindlII; E, EcoRI; X, 
XhoI; A,, polyadenylation site. 
assays (Fig. 2). The endogenous AS RNA is 
alternatively spliced including or deleting 
exon 2 (4) and thus yields two protected 
fragments with the probe used in these assays. 
In cell line R30B4, which expressed relatively 
low levels of RSV-AS mRNA, expression of 
the endogenous A S  gene increased by two 
orders of magnitude upon conversion of cells 
to canavanine-resistance, as expected (Fig. 2, 
lanes c and d). Surprisingly, however, we 
observed a concomitant 10- to 15-fold 
decrease in RSV-AS expression upon induc- 
tion of the endogenous A S  gene in canavan- 
ine-resistance cells9 The observed down-mod- 
ulation was observed in two other independent 
cell lines that also expressed low levels of 
RSV-AS (data not shown)9 These findings 
ln t l lca teu  Lnat expression of all / ~  t;L~• 
minigene was regulated in a reciprocal fashion 
to the endogenous A S  gene and raised the 
possibility that the two A S  genes (mRNAs) 
were competing for a common regulatory 
mechanism in canavanine-resistant cells9 In 
contrast, in cell line R30B2, which expressed 
high levels of RSV-AS mRNA, the endoge- 
nous AS mRNA was only minimally induced 
Fig. 2. Quantification of endogenous AS and AS cDNA 
minigene RNA using S1 nuclease analysis. Fifty micro- 
grams of total cellular RNA were used in all assays. "l~he 
probe was linearized RSV-AS 5' end-labeled at the 
HindlII site in AS cDNA sequences. The endogenous AS 
mRNA lacking exon 2 gives a wide region of protection 
when using this probe and is probably the result of 
"nibbling" by S1 nuclease. The identities of the protected 
fragments are indicated. H, HindlII; E, EcoRI. The 
numbers on the left indicate the migration of DNA 
markers (MspI-digested pUC-9). 
upon conversion of cells to canavanine-resis- 
tance, while RSV-AS expression was essen- 
tially unchanged (Fig. 2, lanes a and b). It is 
l i k e l y  LtlI:t_L LII~ U I I L I U ~ I I U U : ~  /~*..~ l l l I ~ l ~ l / ~  ~vV~S 
induced only slightly in cell line R30B2 since 
these cells were partially resistant to canavan- 
ine, probably due to the high levels of RSV- 
AS mRNA. 
Other cell lines (N > 10) that acquired 
canavanine-resistance without inducing the 
endogenous A S  gene did not exhibit down- 
modulation of RSV-AS expression (unpub- 
126 Boyce et al. 
lished data). Since these cell lines contain a 
full-length AS cDNA minigene that does not 
produce a functional AS enzyme (see below), 
they have acquired resistance to canavanine 
through an alternative mechanism that does 
not involve high A S  expression. Thus, it is 
clear that  down-modulation of RSV-AS 
expression is not due to a culture artifact and 
requires concomitant induction of the endoge- 
nous A S  gene. 
In order to be certain that the observed 
down-modulation of RSV-AS was not the 
result of selection pressures against recombi- 
nant AS enzyme activity, an additional cell 
line, R31A1, was constructed using an RSV- 
AS minigene containing a frameshift muta- 
tion near the amino terminal end of the AS 
coding region (at amino acid position 53, see 
open arrowhead Fig. 1). Pooled canavanine- 
resistant variants of this cell line also showed a 
10- to 15-fold decrease in RSV-AS expression 
concomitant with induction of the endogenous 
A S  gene (Fig. 3, lanes a and c). To rule out the 
possibility that this paradoxical response was 
due to a nonspecific down-modulation of cel- 
lular mRNAs  in canavanine-resistant cells, 
we examined the expression of another cellu- 
lar gene coding for triose phosphate isomerase 
(TPI) (9). The results show that expression of 
the TPI  gene was unaffected upon conversion 
of cells to canavanine-resistance (Fig. 3, lanes 
a and c). 
It  was possible that the observed down- 
modulation of RSV-AS expression was due to 
a nonspecific effect on the viral promoter or 
polyadenylation sequences contained in these 
minigenes. Therefore,  we examined the 
expression of another  t ransfected gene, 
RSVneo, which also utilizes the same RSV 
promoter and SV40 splicing and polyadenyla- 
tion sequences contained in RSV-AS. The 
results show that unlike RSV-AS, expression 
of R S  Vneo was unaltered in canavanine-resis- 
tant variants of cell line R31AI (Fig. 4A). To 
confirm that AS cDNA sequences were neces- 
sary for the observed down-modulation, a 
derivative of RSV-AS, RSV-AS A HindlII -  
Fig. 3. S1 nuclease analysis showing down-modulation of 
RSV-AS A HindlII, a minigene containing a frameshift 
mutation. Lanes a and c, 50 #g of total cellular RNA; 
lane b, 10 #g of total cellular RNA. The probe used to 
detect the AS RNAs is the same as that described in the 
legend of Fig. 2. The probe used to detect triose phosphate 
isomerase (TPI) mRNA was a 936-bp EcoRI fragment of 
the human cDNA (9) 5' end-labeled at the EcoRI sites. 
ter, which lacks a substantial portion of the 
AS cDNA was constructed and tested. This 
minigene contains only the 5' terminal 232 
bases of the AS cDNA and lacks approxi- 
mately 1300 bases of cDNA 3' to the Hindl I I  
site (see Fig. 1). As before, this derivative was 
stably introduced into R P M I  2650 cells fol- 
lowed by selection of canavanine-resistant cell 
variants. Quantification of R N A  in parental 
cells and canavanine-resistant cell variants 
revealed that RSV-AS/x Hindl l I - ter  m R N A  
was expressed equally in both cell types (Fig. 
4B). Thus, the paradoxical down-modulation 
of RSV-AS expression in canavanine-resis- 
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Fig. 4. (A) S1 nuclease analysis showing that the down-modulation is specific for AS sequences. Lanes a and b, 12 #g 
of total cellular RNA; lanes c and d, 25 ug of total cellular RNA. The probe used to detect the AS RNAs is the same as 
that described in the legend of Fig. 2. The probe used to detect RSVneo mRNA was RSVneo plasmid DNA (6) 
linearized with BgllI and 5' end-labeled at the BgllI sites. RPMI, RPMI 2650 cell RNA; Can r, Cant-1 cell RNA. (B) 
S1 nuclease analysis showing absence of down-modulation with a truncated derivative of RSV-AS. RSV-AS A 
HindlII-ter contains only those AS sequences 5' to the HindlII site in the AS cDNA (see Fig. 1). Twenty-five 
micrograms of total cellular RNA were used in all assays. The probe used to detect the AS RNAs is the same as in Fig. 
2. The results from three canavanine-resistant cell lines of R32B4 are shown. 
tant  cell variants is specific for AS c D N A  
sequences and the target sequences for this 
regulatory mechanism must  lie 3' to the 
H ind I I I  site in the AS cDNA.  
DISCUSSION 
There are several possible mechanisms 
that  would explain why RSV-AS expression is 
specifically regulated in opposition to the 
endogenous A S  gene upon conversion of cells 
to canavanine-resistance.  For instance, one 
way to explain the observed reciprocal regula- 
tion is to hypothesize the existence of two 
separate regulatory mechanisms.  The c D N A  
minigenes used in these studies are signifi- 
cantly different than the endogenous A S  gene 
in that  they lack AS introns. Thus, one 
mechanism (factor) could interact  with AS 
exon sequences and suppress AS m R N A  
expression, and a second more powerful mech- 
anism could interact  with AS intron sequences 
and increase AS m R N A  expression. The net 
result on the endogenous A S  gene would be 
increased expression in the canavanine-resis-  
tant  cell. In contrast,  RSV-AS would only 
interact  with the negative-acting mechanism 
and thus show decreased expression in canav- 
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anine-resistant cells. Indeed, previous studies 
have shown that the human AS gene is subject 
to two independently acting regulatory mech- 
anisms in RPMI 2650 cells (2, 3), one of 
which results in repression of AS gene expres- 
sion while the other induces AS mRNA levels 
200-fold. However, expression of RSV-AS is 
unaffected by the concentration of arginine in 
the medium (unpublished data); thus, the 
observed down-modulation of RSV-AS ex- 
pression is not the metabolite-mediated 
repression previously described for the natural 
AS gene (1). This observation is consistent 
with the findings that AS promoter-fusion 
genes are subject to repression by arginine in 
RPMI 2650 cells (2, 3). 
Our data are consistent with a model that 
proposes that the endogenous AS gene is 
controlled by a specific and limiting, posi- 
tively-acting, trans-acting mechanism (fac- 
tor) in canavanine-resistant cells and that 
exogenous AS cDNA sequences can compete 
for this mechanism. We have provided three 
lines of evidence supporting the conclusion 
that the observed down-modulation of RSV- 
AS is specific for AS gene sequences: (1) 
expression of another transfected gene, 
RSVneo, which differs from RSV-AS only by 
substitution of neo sequences for AS 
sequences, does not exhibit the down-modula- 
tion; (2) expression of another cellular gene, 
TPI, is not subject to this regulation; and (3) 
deleting a portion of the AS cDNA from 
RSV-AS eliminates the down-modulation. 
The observation that the endogenous AS gene 
and transfected cDNA minigenes are regu- 
lated in a reciprocal fashion suggests that the 
two AS genes (mRNAs) are competing for a 
common mechanism (factor). Thus, it follows 
that this mechanism (factor) must be limiting, 
otherwise the apparent competition would not 
have been observed. If this competition model 
is correct, the mechanism (factor) must be 
positive-acting since RSV-AS expression 
decreases concomitantly with increased ex- 
pression of the endogenous AS gene. This 
conclusion is based on the expectation that 
titration of a negative-acting mechanism (fac- 
tor), by increasing expression of the endoge- 
nous AS gene, would have resulted in 
derepression of RSV-AS expression. The 
mechanism is clearly trans-acting since 
expression of exogenously added AS cDNA 
minigenes is affected. Finally, the mechanism 
appears to be operating in the nucleus since 
canavanine-resistant variants of R30B2 cells 
also contain reduced amounts of RSV-AS 
RNA in the poly(A)- RNA fraction (unpub- 
lished observations). 
Is this model consistent with all known 
facts regarding regulation of the endogenous 
AS gene in canavanine-resistant cells? Other 
studies from this laboratory have shown that 
high expression of AS mRNA is mediated 
through a positive-acting mechanism operat- 
ing in the nucleus of canavanine-resistant cells 
(7). Furthermore, studies using canavanine- 
resistant lymphoblasts have indicated that 
this mechanism is trans-acting (2). Thus, our 
model, which invokes the existence of a single, 
positively-acting, trans-acting nuclear mecha- 
nism (factor), is consistent with all known 
facts regarding high AS expression in canav- 
anine-resistant cells. Our model requires that 
this mechanism (factor) be limiting, suggest- 
ing that its efficiency, but not its concentra- 
tion, increases in canavanine-resistant cells. 
Therefore, the model invokes a change in the 
affinity of this mechanism (factor) for AS 
gene (mRNA) sequences and that the affinity 
for endogenous AS gene (mRNA) sequences 
is greater than the affinity for RSV-AS gene 
(mRNA) sequences in canavanine-resistant 
cells. This mechanism (factor) could have 
different affinities for the endogenous AS 
gene (mRNA) and RSV-AS gene (mRNA) if 
it interacts with AS intron sequences that are 
absent from RSV-AS. Alternatively, it could 
recognize a unique secondary structure in the 
endogenous AS RNA. However, since mini- 
genes containing only AS cDNA sequences 
are subject to the down-modulation, this 
mechanism (factor) must interact with AS 
exon sequences. It is important to note that 
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this model makes no assumption whether the 
down-modulation involves A S  gene or R N A  
sequences and thus is consistent with a mecha- 
nism that acts either at the transcriptional or 
posttranscriptional level. 
Support for this model will require map- 
ping the sequences involved in this regulation 
and construction of RSV-AS derivatives con- 
taining AS intron sequences. Our task is made 
more difficult by the large size of the human 
A S  gene (63 kb) and the large number of 
introns (4). Nevertheless, it is clear that the 
human A S  gene is subject to a novel regula- 
tory mechanism that warrants further investi- 
gation. 
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